Category Research project
  • Analytik

Advances High Aspect Ratio and Multicomponent materials: towards comprehensive intelligent testing and Safe-by-Design Strategies

Project status
In the closing process
Project start
Jan 2021
Project end
Jan 2025
Acronym
HARMLESS
Department
Chemikalien- und Produktsicherheit

Description and Objective

Great efforts on nanosafety research have been made in the past decades. However, the focus was on rather simple nanomaterials. The fast development of next generation multicomponent nanomaterials demands the continuous adaptation of test and assessment strategies. Complex multi-component, hybrid nanomaterials (MCNM) and High Aspect Ratio Nanomaterials (HARN) exhibit e.g. differing rates of fragmentation, degradation and leaching, along with differing toxicities of the separate components. HARMLESS develops comprehensive intelligent test, assessment and Safe-by-Design strategies for MCNM and HARNs by integrating a toolbox of New Approach Methodologies (NAMs) also considering the ModeModeTo glossary of Action of these materials. To support the later application HARMLESS also develops a user-friendly decision support system and verifies its approach in industrial case studies.
Type of project

Third-party funded project

Areas of research

Nanotechnologie: Nachweis, Toxikologie, Risikobewertung und Risikowahrnehmung

Organisational units and partners

Lead unit: Faser- und Nanotoxikologie (76)
External partner: Helmholtz Zentrum München – Deutsches Zentrum für Gesundheit und Umwelt (GmbH), Karolinska-Institut, The Netherlands Organization for Applied Scientific Research, The National Research Centre For The Working Environment, BioNanoNet Forschungsgesellschaft mbH, IDEAconsult Ltd., BASF SE, Nouryon Pulp and Performance Chemicals AB, Bundesanstalt für Arbeitsschutz und Arbeitsmedizin, Swansea University, French Alternative Energies and Atomic Energy Commission, Universität Danzig, Spanish National Research Council, Technische Universität Dänemark, Temas Solutions GmbH, Misvik Biology Ltd, Universität Lund, European Research Services GmbH

Funding body and grant number

Europäische Union
Grant Agreement 953183